Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Long-term improvement in glycemic control seen with real-time continuous glucose monitoring (CGM) is similar whether used in a patient self-management protocol or in…
NEW YORK (Reuters Health) – Cigarette smoking enhanced the effects of clopidogrel in a study of diabetics with coronary artery disease. Accordingly, smokers were less likely to experience…
NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in first-time users of oral bisphosphonates. “Patients taking bisphosphonates must be familiar…
NEW YORK (Reuters Health) – The investigational GLP-1 receptor antagonist lixisenatide significantly reduces postprandial glucose excursions and HbA1c in patients with type 2 diabetes who have not been…
NEW YORK (Reuters Health) – In patients with type 2 diabetes whose glucose levels are inadequately controlled on high doses of insulin, the addition of dapagliflozin improves HbA1c…
NEW YORK (Reuters Health) – Iron-deficiency anemia can lead to high glycosylated hemoglobin (HbA1c) concentrations that do not reflect glycemic parameters, an Indian study has shown. “The use…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, glycemic control is better and weight loss is sustained up to 84 weeks with exenatide once weekly…
NEW YORK (Reuters Health) – Increases in fasting blood sugar levels are often seen in patients starting niacin, sometimes to a level that suggests new onset of type…
NEW YORK (Reuters Health) – Cabergoline in combination with low-dose pegvisomant is effective in treating patients with active acromegaly, researchers from UK report in the January 25th online…
NEW YORK (Reuters Health) – Results of a study confirm that treatment with dapagliflozin helps patients with type 2 diabetes lose weight in addition to improving their blood…
